본문 바로가기
KERD
논문KCI 등재

Antifungal Activity of Bee Venom and Sweet Bee Venom against Clinically Isolated Candida albicans

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives: The purpose of this study was to investigate the antifungal effect of bee venom (BV) and sweet bee venom (SBV) against Candida albicans (C. albicans) clinical isolates. Methods: In this study, BV and SBV were examined for antifungal activities against the Korean Collection for Type Cultures (KCTC) strain and 10 clinical isolates of C. albicans. The disk diffusion method was used to measure the antifungal activity and minimum inhibitory concentration (MIC) assays were performed by using a broth microdilution method. Also, a killing curve assay was conducted to investigate the kinetics of the anti- fungal action. Results: BV and SBV showed antifungal activity against 10 clinical isolates of C. albicans that were cultured from blood and the vagina by using disk diffusion method. The MIC values obtained for clinical isolates by using the broth microdilution method varied from 62.5 μg/ mL to 125 μg/mL for BV and from 15.63 μg/mL to 62.5 μg/mL for SBV. In the killing-curve assay, SBV behaved as amphotericin B, which was used as positive control, did. The antifungal efficacy of SBV was much higher than that of BV. Conclusion: BV and SBV showed antifungal activity against C. albicans clinical strains that were isolated from blood and the vagina. Especially, SBV might be a candidate for a new antifungal agent against C. albicans clinical isolates.

Abstract

Objectives: The purpose of this study was to investigate the antifungal effect of bee venom (BV) and sweet bee venom (SBV) against Candida albicans (C. albicans) clinical isolates. Methods: In this study, BV and SBV were examined for antifungal activities against the Korean Collection for Type Cultures (KCTC) strain and 10 clinical isolates of C. albicans. The disk diffusion method was used to measure the antifungal activity and minimum inhibitory concentration (MIC) assays were performed by using a broth microdilution method. Also, a killing curve assay was conducted to investigate the kinetics of the anti- fungal action. Results: BV and SBV showed antifungal activity against 10 clinical isolates of C. albicans that were cultured from blood and the vagina by using disk diffusion method. The MIC values obtained for clinical isolates by using the broth microdilution method varied from 62.5 μg/ mL to 125 μg/mL for BV and from 15.63 μg/mL to 62.5 μg/mL for SBV. In the killing-curve assay, SBV behaved as amphotericin B, which was used as positive control, did. The antifungal efficacy of SBV was much higher than that of BV. Conclusion: BV and SBV showed antifungal activity against C. albicans clinical strains that were isolated from blood and the vagina. Especially, SBV might be a candidate for a new antifungal agent against C. albicans clinical isolates.

참고문헌 (40)

  1. Odds FC, "Candida species and virulence", Am Soc Microbiol News, 60(6), pp.313~318 (1994)
  2. Verduyn Lunel FM, "Nosocomial fungal infections : candidemia", Diagn Microbiol Infect Dis, 34(3), pp.213~220 (1999)
  3. McNeil MM, "Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997", Clin Infect Dis, 33(5), pp.641~647 (2001)
  4. Bodey GP, "The emergence of fungi as major hospital pathogens", J Hosp Infect, 11(Suppl A), pp.411~426 (1988)
  5. Edwards JE Jr, "Invasive candida infections-evolution of a fungal pathogen", N Engl J Med, 324(15), pp.1060~1062 (1991)
  6. Fisher-Hoch SP, "Opportunistic candidiasis : an epidemic of the 1980s", Clin Infect Dis, 21(4), pp.897~904 (1995)
  7. Edwards JE Jr, "International conference for the development of a consensus on the management and prevention of severe candidal infections", Clin Infect Dis, 25(1), pp.43~59 (1997)
  8. Anttila VJ, "Hepatosplenic yeast infection in patients with acute leukemia : a diagnostic problem", Clin Infect Dis, 18(6), pp.979~981 (1994)
  9. Gallis HA, "Amphotericin B: 30 years of clinical experience", Rev Infect Dis, 12(2), pp.308~329 (1990)
  10. Hartsel S, "Amphotericin B: new life for an old drug", Trends Pharmacol Sci, 17(12), pp.445~449 (1996)
  11. Matsuoka S, "Cholesterol markedly reduces ion permeability induced by membrane-bound amphotericin B", Biochim Biophys Acta, 1564(2), pp.429~434 (2002)
  12. Fonos V, "Amphotericin B-induced nephrotoxicity : a review", J Chemother, 12(6), pp.463~470 (2000)
  13. Mayer J, "Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study", J Infect Dis, 186(3), pp.379~388 (2002)
  14. 이승하, "Rhodococcus sp. EH831에 의한 벤젠, 톨루엔 및 에틸벤젠의 호기성 생분해에 미치는 에탄올의 영향", 한국미생물·생명공학회지, 37(3), pp.243~247 (2009), 한국미생물·생명공학회
  15. Kwon YB, "The water-soluble fraction of bee venom produces anti-nociceptive and antiinflammatory effects on rheumatoid arthritis in rats", Life Sci, 71(2), pp.191~204 (2002)
  16. Kim HW, "Acupoint stimulation using bee venom attenuates formalin induced pain behavior and spinal cord fos expression in rats", J Vet Med Sci, 65(3), pp.349~355 (2003)
  17. Sangmi Han, "Antibacterial Activity of the Honey Bee Venom against Bacterial MastitisPathogens Infecting Dairy Cows", International Journal of Industrial Entomology, 14(2), pp.137~142 (2007), 한국잠사학회
  18. Lee SM, "Bee venom treatment for refractory postherpetic neuralgia : a case report", J Altern Complement Med, 20(3), pp.212~214 (2014)
  19. Choi SH, "Effect of apitherapy in piglets with preweaning diarrhea", Am J Chin Med, 31(2), pp.321~326 (2003)
  20. Park HJ, "Anti-arthritic effect of bee venom : inhibition of inflammation mediator generation by suppression of NF-B through interaction with the p50 subunit", Arthritis Rheum, 50(11), pp.3504~3515 (2004)
  21. 최영권, "Gel filtration chromatography와 propionic acid", urea polyacrylamide gel electrophoresis를 이용한 봉독 성분의 분리, 2006, pp.9(2), 105~111[DOI]
  22. Eiseman JL, "Effect of honeybee(Apis mellifera)venom on the course of adjuvant-induced arthritis and depression of drug metabolism in the rat", Biochem Pharmacol, 31(6), pp.1139~1146 (1982)
  23. Akdis CA, "Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro", J Clin Invest, 98(7), pp.1676~1683 (1996)
  24. Kwon YB, "Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses", Pain, 90(3), pp.271~280 (2001)
  25. Espinel-Ingroff A, "International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole", J Clin Microbiol, 43(8), pp.3884~3889 (2005)
  26. Klepser ME, "Influence of test conditions on antifungal time-kill curve results : proposal for standardized methods", Antimicrob Agents Chemother, 42(5), pp.1207~1212 (1998)
  27. Owens WE, "Prevalence of mastitis in dairy heifers and effectiveness of antibiotic therapy", J Dairy Sci, 84(4), pp.814~817 (2001)
  28. Pitkälä A, "Bovine mastitis in Finland 2001-prevalence, distribution of bacteria, and antimicrobial resistance", J Dairy Sci, 87(8), pp.2433~2441 (2004)
  29. Nair MK, "Antibacterial effect of caprylic acid and monocaprylin on major bacterial mastitis pathogens", J Dairy Sci, 88(10), pp.3488~3495 (2005)
  30. Komine Y, "Effect of combination therapy with lactoferrin and antibiotics against staphylococcal mastitis on drying cows", J Vet Med Sci, 68(3), pp.205~211 (2006)
  31. Fennell JF, "Antibacterial action of melittin, a polypeptide from the venom", Proc Soc Exp Biol Med, 127(3), pp.707~710 (1968)
  32. Somerfield SD, "Bee venom inhibits superoxide production by human neutrophils", Inflammation, 8(4), pp.385~391 (1984)
  33. Saini SS, "Melittin binds to secretory phospholipase A2 and inhibits its enzymatic activity", Biochem Biophys Res Commun, 238(2), pp.436~442 (1997)
  34. Stocker JF, "The action of various venoms on Escherichia coli", J Appl Bacteriol, 61(5), pp.383~388 (1986)
  35. Perumal Samy R, "Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes", J Appl Microbiol, 102(3), pp.650~659 (2007)
  36. Nakatuji T, "Antimicrobial property of lauric acid against Propionibacterium acnes: Its therapeutic potential for inflammatory acne vulgaris", J Invest Dermatol, 129(10), pp.2480~2488 (2009)
  37. Han SM, "Antibacterial and anti-inflammatory effects of honeybee (Apis mellifera) venom against acne-inducing bacteria", J Med Plants Res, 4(6), pp.459~464 (2010)
  38. A-Reum Yu, "The Antifungal Activity of Bee Venom against Dermatophytes", Journal of Applied Biological Chemistry, 55(1), pp.7~11 (2012), 한국응용생명화학회
  39. 성인화, "오배자 추출물의 Candida albicans에 대한 항진균 활성", 대한의진균학회지, 12(4), pp.175~179 (2007), 대한의진균학회
  40. 성인화, "백작약 추출물의 Candida albicans에 대한 항진균 활성", 대한의진균학회지, 11(1), pp.19~26 (2006), 대한의진균학회

관련 논문AI추천

이 간행물의 다른 논문 (8건)